- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03394274
Restrictive Versus Liberal Transfusion, Major Surgeries (transfusion)
January 10, 2018 updated by: Leyla Kılınc
Restrictive Versus Liberal Transfusion for Elective Major Surgery and Perioperative Outcomes: Mortality, Morbidity and Requirement of Postoperative Blood Transfusion
Investigators aimed to compare the restrictive and liberal blood transfusion methods applied in major surgical operations performed in Anesthesiology and Reanimation Clinic and investigate their effects on postoperative transfusion needs, morbidity and mortality.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The test subjects consisted of 892 patients, who belong to ASA (American society of Anesthesiology) I -IV groups, underwent elective major surgery between the 01/01/2016-31/12/2016, and are over the age of 18 years.
The demographic data (Age, sex, ASA (American society of Anesthesiology) scors, surgery type) were also recorded.
we evaluated the value of Hemoglobin, platelet, APTT (activated partial thromboplastin time), INR (international normalized ratio) preoperatively and postoperatively.
In this study, restrictive and liberal blood transfusion groups were investigated.restrictive
and liberal transfusion hemoglobin threshold value respectively before perioperative transfusion was 8 g / dL. were defined as restrictive blood transfusion group and perioperative transfusion was over 8 g / dL were defined as liberal blood transfusion group.
Adverse events (tachycardia, hypotension, the value of lactate and metabolic acidosis).
Postoperatively, the amount of postoperative transfusion unit, duration of hospital stay, requirement of intensive care unit and mortality rate.
Study Type
Observational
Enrollment (Actual)
892
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34371
- University of Health sciences,sisli Hamidiye Etfal Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Over 18 years old patients, ASA I-II-III-IV, major surgeries ( Intraabdominal, intracranial, head and neck malignanacy surgery, femur and vertebra surgery) were enrolled.
Description
Inclusion Criteria:
- Over 18 years old patients,
- ASA I-II-III-IV,
- Major surgeries ( Intra-abdominal, intracranial, head and neck malignancy surgery, femur and vertebra surgery)
Exclusion Criteria:
- Emergency operation,
- Cardiovascular surgery,
- ASA V-VI
- Under 18 years old patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Transfusion
Patients (n:892) were enrolled who underwent elective major surgery between the 01/01/2016-31/12/2016, and over the age of 18 years.
They separated subgroups as restrictive and liberal blood transfusion groups
|
hemoglobin threshold value was accepted 8g/dl.
restrictive blood transfusion group was defined that if perioperative transfusion was started equal or under hemoglobin level 8 g / dL.
Liberal blood transfusion group was defined as perioperative transfusion was started over hemoglobin level 8 g / dL .
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Restrictive or Liberal transfusion
Time Frame: 52 weeks
|
It is determined how many units of RBC (red blood cell ) used during major operations at the hospital in liberal transfusion group or restrictive transfusion group.
|
52 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality
Time Frame: 52 weeks
|
Survival ratios between the restrictive transfusion group and the liberal transfusion group are compared.
|
52 weeks
|
Postoperative transfusion requirement
Time Frame: 52 Weeks
|
The requirement of postoperative blood transfusion between the restrictive transfusion group and the liberal transfusion group is determined.
|
52 Weeks
|
The Need of ICU
Time Frame: 52 Weeks
|
The need of ICU between the restrictive transfusion group and the liberal transfusion group of patients is determined.
|
52 Weeks
|
Postoperative Duration of Stay in Hospital of patients
Time Frame: 52 Weeks
|
The postoperative duration of stay in hospital of patients between the restrictive transfusion group and the liberal transfusion group are compared.
|
52 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 14, 2017
Primary Completion (Actual)
September 15, 2017
Study Completion (Actual)
November 15, 2017
Study Registration Dates
First Submitted
November 27, 2017
First Submitted That Met QC Criteria
January 6, 2018
First Posted (Actual)
January 9, 2018
Study Record Updates
Last Update Posted (Actual)
January 11, 2018
Last Update Submitted That Met QC Criteria
January 10, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 814
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
there is no plan to make individual participant data (IPD) available to other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transfusion Related Complication
-
Institutul Clinic FundeniCompletedTransfusion Related ComplicationRomania
-
Centre Hospitalier Universitaire de BesanconUnknownTransfusion Related Complication
-
RenJi HospitalNot yet recruitingTransfusion Related Complication
-
University Hospital, CaenUnknownTransfusion Related ComplicationFrance
-
Centre Hospitalier Universitaire de BesanconTerminatedPostoperative; Dysfunction Following Cardiac Surgery | Transfusion Related ComplicationFrance
-
Samsung Medical CenterUnknownBleeding | Transfusion Related ComplicationKorea, Republic of
-
James ReynoldsNational Heart, Lung, and Blood Institute (NHLBI); Case Western Reserve UniversityRecruitingTransfusion Related ComplicationUnited States
-
The Mediterranean Institute for Transplantation...Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Medical University... and other collaboratorsCompletedHemorrhage | Extracorporeal Membrane Oxygenation Complication | Anticoagulant-induced Bleeding | Transfusion Related ComplicationItaly
-
Patrick HennCompletedTransfusion Related Complication | Wrong Blood in TubeIreland
-
Second Affiliated Hospital, School of Medicine,...CompletedSpinal Fusion | Pulmonary Complication | TransfusionChina
Clinical Trials on restrictive and liberal transfusion
-
University of EdinburghNHS Lothian; Chief Scientist Office of the Scottish Government; Transfusion Medicine...CompletedAnemia | Blood Transfusion | Intensive CareUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedMyocardial Infarction | Anemia | Blood TransfusionSpain, France
-
Guangdong Provincial People's HospitalNot yet recruitingValve Heart Disease | Cardiac Surgery With Cardiopulmonary BypassChina
-
University of Sao PauloCompleted
-
Unity Health TorontoRecruitingCardiac Surgery | Heart | Postoperative | DisorderCanada, Russian Federation
-
Instituto do CoracaoUnknown
-
Aretaieion University HospitalCompletedSurgery | Cytokine Storm | Infection After Transfusion | Transfusion-related Immunomodulation ReactionGreece
-
Nadine ShehataCanadian Institutes of Health Research (CIHR); Health CanadaCompleted
-
Unity Health TorontoCompletedDisorder; Heart, Functional, Postoperative, Cardiac SurgeryCanada, Spain, United States, Israel, Australia, New Zealand, Denmark, Colombia, Egypt, Germany, Singapore, Switzerland, China, Brazil, Greece, India, Malaysia, Romania, South Africa
-
Erasme University HospitalEuropean Society of Intensive Care MedicineCompletedBlood Transfusion | Acute Brain InjuryBelgium